Linkage between Efficiency of Assets Management and Profitability in Selected Companies in Pharmaceutical Industry

2014 ◽  
pp. 207-221
Author(s):  
Kaushik Chakraborty
Keyword(s):  
Pharmaceutical Industry ◽  
Sample Size ◽  
Asset Management ◽  
Pharmaceutical Companies ◽  
Statistical Tools ◽  
Tools And Techniques ◽  
The Relationship ◽  
Domestic Companies ◽  
Indian Pharmaceutical Industry ◽  
Assets Management

This chapter empirically investigates the relationship between the efficiency of asset management and profitability of the Indian pharmaceutical industry during the period 2002-03 to 2011-12. The chapter also tries to make a comparison, in respect of the efficiency of assets management, between multinational and domestic companies in the Indian pharmaceutical industry during the same period. The sample size of the study consists of 20 pharmaceutical companies by taking 10 multinational and 10 domestic companies from the Indian pharmaceutical industry. The issues analyzed in this study have been tackled using relevant statistical tools and techniques.

Assets Management of the Indian Pharma Sector in the Changing Socio-Cultural and Business Environment of Post-Liberalization Era

2016 ◽  
pp. 47-66
Author(s):  
Kaushik Chakraborty
Keyword(s):  
Pharmaceutical Industry ◽  
Rapid Change ◽  
Business Environment ◽  
Wealth Maximization ◽  
Financial Applications ◽  
Tools And Techniques ◽  
The Relationship ◽  
Domestic Companies ◽  
Indian Pharmaceutical Industry ◽  
Assets Management

Efficiency of assets management is an absolutely unavoidable issue in accomplishing the wealth maximization objective of business. In India, the changing scenario in the front of demographic, social and cultural made a prominent impact on the growth of pharmaceutical industry. In fact, during the last two decades the changing socio-cultural and business environment of India witnessed a rapid change in various managerial as well as financial applications of the Indian pharma sector. Assets management is no doubt a vital part of the overall strategy for achieving financial objectives of any industry. In this backdrop, the present study empirically investigates the relationship between the efficiency of assets management and profitability of the Indian pharmaceutical industry during the period 1998-99 to 2012-13 and also examines whether its findings conform to the theoretical arguments. Besides this, the paper also tries to make a comparison, in respect of the efficiency of assets management, between multinational and domestic companies in the Indian pharmaceutical industry during the same period to know whether changing socio-cultural and business environment gives an age to domestic companies in respect of assets management or not. The sample size of the study consists of ten pharmaceutical companies by taking five multinational and five domestic companies from the Indian pharmaceutical industry. The issues analyzed in this study have been tackled using relevant statistical tools and techniques.

Impact of Financial Risk Ratios on Profitability of Multinational vs. Domestic Pharmaceuticals in India

2014 ◽  
Vol 3 (2) ◽  
pp. 54-68
Author(s):  
Kaushik Chakraborty
Keyword(s):  
Pharmaceutical Industry ◽  
Strong Evidence ◽  
Corporate Strategy ◽  
Business Environment ◽  
Multinational Companies ◽  
High Tech ◽  
Financial Leverage ◽  
The Relationship ◽  
Domestic Companies ◽  
Indian Pharmaceutical Industry

The impact of financial leverage on the profitability position of the business firms under different financing alternatives and with varying levels of overall profitability is one of the most crucial issues in modern finance to sustain continuous improvement in financial performance. In fact, framing an appropriate capital structure with flexible equity and disciplined debt financing is an integral part of the entire corporate strategy to gain shareholder confidence and stakeholder support to achieve long run sustainability. No firm can ignore this aspect in the context of today's high-tech competitive business environment. Unfortunately this issue has not been addressed with due importance in India and in particular, no significant study exists on the pharmaceutical sector comparing the linkage between financial leverage and profitability of multinational companies with that of the domestic companies. The pharmaceutical industry is acknowledged as one of the most promising industries in India; therefore this study should make a significant contribution to the practice. This paper examines the relationship between financial leverage and profitability of the Indian pharmaceutical industry during the period of March 2002 to December 2011 (N=20). The researcher compared the relationship between financial leverage and profitability of multinational companies with that of the domestic companies in the Indian pharmaceutical industry. The research found strong evidence of the negative contribution of financial leverage towards improving profitability for multinational and domestic firms. Hence, these results provide strong evidence of positive contribution of financial leverage towards improving profitability in a substantial portion of the sample companies during the study period.

scholarly journals Effect of Financial Performance on Profitability in Indian Pharmaceutical Companies

2019 ◽  
Vol 8 (6) ◽  
pp. 4910-4916
Keyword(s):  
Pharmaceutical Industry ◽  
Financial Performance ◽  
National Economy ◽  
Pharmaceutical Companies ◽  
Government Control ◽  
Pharmaceutical Sector ◽  
Drug Store ◽  
Indian Pharmaceutical Industry

The total Indian pharmaceutical sector is exceedingly divided with in excess of 20,000 enlisted units. It has spread drastically over the most recent two decades. The pharmaceutical and the chemical industries in India is an amazingly separated market with solid value rivalry and government control. The pharmaceutical business in India meets around 705 of the nation's interest in bulk medications, pharmaceutical formulas, synthetics, tablets, oral and injectables. There are around 250 enormous units and around 8,000 SMUs, which structure the centre of the pharmaceutical business in India, including 4 Pubilc sector units. Looking forward, the worldwide drug store market is assessed at more than to 1.5 billion dollars constantly in 2020. The Indian pharmaceutical industry is growing significantly every year. The primary goal of this research unmistakably demonstrates that pharmaceutical organizations are working great as an industry as well as can add growth to the development of the national economy. In this way, we made an attempt to find the effect of financial performance on profitability.

Working Capital Management in Select Indian Pharmaceutical Companies

2014 ◽  
pp. 1-11
Author(s):  
Debasish Sur ◽  
Sumit Kumar Maji ◽  
Deep Banerjee
Keyword(s):  
Pharmaceutical Industry ◽  
Competitive Environment ◽  
Common Phenomenon ◽  
Capital Management ◽  
Working Capital ◽  
Working Capital Management ◽  
Efficient Management ◽  
The World ◽  
Tools And Techniques ◽  
Indian Pharmaceutical Industry

The Indian pharmaceutical industry is the fifth largest pharmaceutical industry in the world in terms of volume and the fourteenth largest in value terms. There have been sevaral notable changes in the scenario of Indian pharmaceutical industry after the signing of GATT (now WTO). The mergers, acquisitions, and takeovers at both national and international levels have become a common phenomenon in this industry. In today's challenging and competitive environment, efficient management of working capital is an integral component of the overall strategy to create shareholders' wealth. So, the task of designing appropriate strategies for managing working capital in accomplishing the objective of maximizing shareholders' wealth of companies in the Indian pharmaceutical industry is of prime importance. In this backdrop, the chapter seeks to analyze the working capital management of ten selected companies in the Indian pharmaceutical industry during the period 1996-97 to 2010-11. While satisfying the objective of the study, relevant statistical tools and techniques have been applied at appropriate places.

scholarly journals Pharmacotherapy and child psychiatry: is there a way forward?

2008 ◽  
Vol 14 (1) ◽  
pp. 10-16 ◽  
Author(s):  
A. James
Keyword(s):  
Pharmaceutical Industry ◽  
Child Psychiatry ◽  
New Drugs ◽  
Pharmaceutical Companies ◽  
Drug Treatments ◽  
New Guidelines ◽  
Post Trial ◽  
Relationship Of ◽  
The Relationship

Recent controversy over the use of serotonin reuptake inhibitors in children and adolescents has focused attention on the role of the pharmaceutical industry in the treatment of young people. Failure of pharmaceutical companies to fully disclose negative outcome trials has led to new guidelines for publication of all trial results. Scrutiny is on the conduct of trials and the relationship of the pharmaceutical industry with prescribing doctors and post-trial surveillance of new drugs. It is argued that drug treatments in child psychiatry are a powerful therapeutic tool but vigilance is needed to ensure that data on the efficacy and safety of drugs are freely available.

scholarly journals A Comparative Study of Profitability of Selected Pharma Companies of India

2018 ◽  
Vol 7 (1) ◽  
pp. 27
Author(s):  
Bhavik U. Swadia
Keyword(s):  
Pharmaceutical Industry ◽  
Comparative Study ◽  
Major Change ◽  
Pharmaceutical Companies ◽  
Basic System ◽  
Foreign Product ◽  
Pharmaceutical Manufacturers ◽  
Long Time ◽  
Production Value ◽  
Indian Pharmaceutical Industry

The Indian pharmaceutical industry is growing rapidly in the number of production, value, quantity, units and there are two main things that appear to conform to the story of the full growth of the Indian economy. Second, there has been a major change in the very basic system of pharmaceutical business in India. By issuing a patent ordinance, India fulfills WTO's commitment to identify foreign product patents from January 1, 2005, the culmination of the 10-year process. In this new scenario, Indian pharmaceutical manufacturers will not be able to manufacture patented drugs, which they have been doing for a long time, though by another process. This study has been done for important evaluation of India's pharmaceutical industry. This study focus on to analyse the profitability of the selected pharmaceutical companies of India and to study the relation between the pharmaceutical companies for various measures of profitability. The study period is ten years from 2007-08 to 2016-17. Based on the study it can be seen that pharmaceutical companies had a very good profitability in 2008, while the weakest profitability of all time in year 2015.

scholarly journals Modelling the Enablers of Green and Sustainable Practices in Indian Pharmaceutical Industry- An ISM Approach

2021 ◽  
pp. 65-74
Author(s):  
Miloni Raiyarela ◽  
Smita Mehendale
Keyword(s):  
Pharmaceutical Industry ◽  
Literature Review ◽  
Environmental Issues ◽  
Pharmaceutical Companies ◽  
Structural Modelling ◽  
Negative Effects ◽  
Management Commitment ◽  
Top Management Commitment ◽  
Level Model ◽  
Indian Pharmaceutical Industry

Rising environmental issues and production of hazardous waste by the pharmaceutical industry has created a harmful impact on society, the environment, and pharmaceutical companies' reputation. It has given rise to the need to adopt and integrate green and sustainable pharmaceutical company’s practices to mitigate environmental degradation's negative effects. The aim is to identify hierarchical interrelationships between these variables and determine their significance through MICMAC analysis and Interpretive Structural Modelling (ISM). The study identified ten significant enablers by exploring literature review and consultation with the industry experts from the Indian Pharmaceutical sector, which led to an understanding of their interrelationships. A four-level model was derived through the ISM technique. Pressure from the customer was found to be the most important enabler, followed by top management commitment and regulation. These enablers carry high driving power. The model developed through this study will help the pharmaceutical companies and their managers to implement green processes systematically.

scholarly journals Public Opinion on Water Scarcity With Special Reference To Chennai

2019 ◽  
Vol 8 (11) ◽  
pp. 3184-3187
Keyword(s):  
Public Opinion ◽  
Special Reference ◽  
Sample Size ◽  
Fresh Water ◽  
Water Scarcity ◽  
Future Generations ◽  
Statistical Tools ◽  
Chi Square ◽  
The Public ◽  
The Relationship

Water scarcity is the most prevailing problem that is existing in day to day life.The main reason for water scarcity and parts which were affected by acute water scarcity is discussed. The alarming water scarcity especially fresh water scarcity is also discussed here. The percentage of people who are suffering from severe water scarcity is also discussed. This research made to analysis the water scarcity in various areas in Chennai.The main objective of this research is to understand the problems of water scarcity with people. To analyse the relationship between public and the prevailing water scarcity.In this study we will discuss about the water scarcity among the public. The statistical tools used are ANOVA, independent t test and chi-square. The sample size is 1480 samples.This research concludes that within few years there will be no water for our future generations.

scholarly journals L’influence Des Pratiques Marketing Des Laboratoires Pharmaceutiques Sur L’éthique De La Fonction Médicale Au Maroc

2018 ◽  
Vol 14 (27) ◽  
pp. 57
Author(s):  
Mohammed Saad Eddine ◽  
Anouar Ammi
Keyword(s):  
Pharmaceutical Industry ◽  
Public Relations ◽  
Ethical Code ◽  
Pharmaceutical Companies ◽  
Medical Field ◽  
Medical Sector ◽  
Material Interests ◽  
The Relationship ◽  
First World ◽  
Pharmaceutical Laboratories

In Morocco and unlike the first world countries, and with the absence of the ethical code of medical promotion, a lot of pharmaceutical companies use the gifts policy in order to influence the doctors prescribing to the patients. Concerning the Moroccan pharmaceutical industry, a study made by the competition council in 2011 showed that the existence of dubious practices that goes against the patient’s interest. These practices are often materialized by public relations actions between the stakeholders operating in the medical field in the doctor’s favor, especially the aspects of the heavy and expensive pathologies. While medicine is usually governed by some very strict rules of ethnics and morals, this article aims to analyze the nature of the links that governs the relationship between the pharmaceutical laboratories and the doctors of different specialties; different scales and different areas in Morocco. The article will present a set of elements that demonstrate on the basis of the sample studied that the relationship between the various stakeholders operating in the medical sector is still not healthy, and that it is strongly impacted by material interests. to the detriment of patients, hence the need to involve professional and state actors for the implementation of a strict ethical code.

scholarly journals A Study of the Impact of Value-Added Efficiency on Profitability and Market Value in the Indian Pharma Industry

2022 ◽  
Vol 11 (1) ◽  
pp. 212
Author(s):  
Shireen Rosario ◽  
Chandra Sen Mazumdar
Keyword(s):  
Pharmaceutical Industry ◽  
Intellectual Capital ◽  
Stock Exchange ◽  
Value Added ◽  
Market Value ◽  
Market Valuation ◽  
Pharmaceutical Companies ◽  
Knowledge Based ◽  
The Impact ◽  
Indian Pharmaceutical Industry

The aim of this paper is to highlight the growing influence of Intellectual Capital (IC) on the profitability and market valuation, especially in knowledge-based industries. The scope of this paper is restricted to the Indian Pharmaceutical Industry, which is highly dependent on IC. This study employs the measure of Value-Added Intellectual Coefficient (VAIC) to assess impact of IC on the profitability and market valuation and to assess the growth of VAIC and its components among the companies over the years selected for the study. The study uses 22 Pharmaceutical companies listed in the Bombay Stock Exchange for a period of 12 years from the financial year 2008-09 to 2019-20. By using Path Analysis, the study demonstrates that the components of VAIC have an impact on the ROCE and market value, which has only grown as compared to earlier studies & years. The study also demonstrates that high sales and profits need not necessarily result in high VAIC.   Received: 7 October 2021 / Accepted: 24 November 2021 / Published: 3 January 2022

Sign in / Sign up

Export Citation Format

Share Document